Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-058488

Chief Medical Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip Chief Medical Officer 2020-11-12 Option exercise +20,000 $0.86 $17,100 49,777 D
Derivatives
Pang Phillip Chief Medical Officer 2020-11-12 Option exercise · Employee Stock Option (Right to Buy) −20,000 61,333 D
Loading xslF345X03/doc4.xml…